Madrigal Pharmaceuticals, Inc. SEC filings MDGL
Madrigal Pharmaceuticals, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Nov 12, 2010. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jun 17, 2026 | — |
| S-8 | Employee stock plan registration | Sep 11, 2025 | — |
| S-8 | Employee stock plan registration | Jun 20, 2025 | — |
| S-8 | Employee stock plan registration | Oct 31, 2024 | — |
| 424B3 | Prospectus | May 7, 2024 | — |
| 424B5 | Prospectus supplement | May 7, 2024 | — |
| S-3ASR | Automatic shelf registration | May 7, 2024 | — |
| 424B5 | Prospectus supplement | Mar 20, 2024 | — |
| 424B5 | Prospectus supplement | Mar 18, 2024 | — |
| 424B5 | Prospectus supplement | Oct 2, 2023 | — |
| 424B5 | Prospectus supplement | Sep 28, 2023 | — |
| S-8 | Employee stock plan registration | Sep 11, 2023 | — |
| 424B3 | Prospectus | Aug 8, 2023 | — |
| 424B5 | Prospectus supplement | May 9, 2023 | — |
| 424B5 | Prospectus supplement | Dec 23, 2022 | — |
| S-8 | Employee stock plan registration | Jun 29, 2021 | — |
| 424B5 | Prospectus supplement | Jun 1, 2021 | — |
| S-3ASR | Automatic shelf registration | Jun 1, 2021 | — |
| S-8 | Employee stock plan registration | Nov 5, 2020 | — |
| 424B5 | Prospectus supplement | Nov 5, 2020 | — |
| 424B7 | Filing | Dec 12, 2019 | — |
| 424B5 | Prospectus supplement | Jun 7, 2018 | — |
| 424B5 | Prospectus supplement | Jun 6, 2018 | — |
| S-3ASR | Automatic shelf registration | Jun 5, 2018 | — |
| S-8 | Employee stock plan registration | Apr 27, 2018 | — |
| 424B5 | Prospectus supplement | Dec 20, 2017 | — |
| 424B5 | Prospectus supplement | Dec 18, 2017 | — |
| 424B3 | Prospectus | Jul 26, 2017 | — |
| S-3 | Shelf registration | Jul 17, 2017 | — |
| S-8 | Employee stock plan registration | Jul 21, 2016 | — |
| 424B5 | Prospectus supplement | Oct 16, 2015 | — |
| S-3 | Shelf registration | Aug 6, 2015 | — |
| S-8 | Employee stock plan registration | Aug 6, 2015 | — |
| 424B5 | Prospectus supplement | Apr 1, 2015 | — |
| 424B5 | Prospectus supplement | Mar 30, 2015 | — |
| S-8 | Employee stock plan registration | Mar 12, 2015 | — |
| 424B5 | Prospectus supplement | Jul 18, 2014 | — |
| POS AM | Filing | May 8, 2014 | — |
| 424B5 | Prospectus supplement | May 8, 2014 | — |
| 424B5 | Prospectus supplement | Apr 14, 2014 | — |
| S-8 | Employee stock plan registration | Mar 11, 2014 | — |
| 424B5 | Prospectus supplement | Nov 14, 2013 | — |
| 424B5 | Prospectus supplement | Nov 12, 2013 | — |
| 424B2 | Prospectus | May 3, 2013 | — |
| S-8 | Employee stock plan registration | Mar 14, 2013 | — |
| S-3 | Shelf registration | Mar 14, 2013 | — |
| 424B5 | Prospectus supplement | Dec 13, 2012 | — |
| 424B5 | Prospectus supplement | Jul 26, 2012 | — |
| S-8 | Employee stock plan registration | May 3, 2012 | — |
| 424B5 | Prospectus supplement | May 3, 2012 | — |
| 424B5 | Prospectus supplement | Jan 6, 2012 | — |
| 424B5 | Prospectus supplement | Jan 5, 2012 | — |
| 424B2 | Prospectus | Aug 19, 2011 | — |
| S-3 | Shelf registration | Aug 4, 2011 | — |
| S-8 | Employee stock plan registration | May 2, 2011 | — |
| 424B5 | Prospectus supplement | Apr 15, 2011 | — |
| 424B5 | Prospectus supplement | Nov 12, 2010 | — |
Showing 57 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MDGL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Conshohocken, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1157601
- Former names
- MADRIGAL PHARMACEUTICALS, INC. (until Nov 3, 2026); SYNTA PHARMACEUTICALS CORP (until Aug 1, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.